Anti-Cholesterol Drug Pulled Off Market

FOR IMMEDIATE RELEASE

Click here to download this press release (.PDF)
 

Anti-Cholesterol Drug Pulled Off Market
OREM, UTAH—A recent announcement that Bayer A.G., a pharmaceutical and chemical
conglomerate, is voluntarily pulling Baycol, its highly profitable cholesterol-lowering drug, off the
market is good news for consumers who prefer to maintain their cholesterol through diet or natural
supplements.
The voluntary move, which is supported by the United States Food and Drug Administration, comes
after the agency received reports of 31 deaths that may be associated with the use of Baycol, 12 of
which involved concomitant gemfibrozil use. The medication reportedly caused rhabdomyolysis, an
unusual condition in which muscle tissue breaks down.
Unicity product Bios Life 2® is a clinically tested, natural, and effective nutrient drink mix that helps
support normal cholesterol and blood sugar levels. This flagship Rexall brand product was recently
featured on a major news television program for its cholesterol-lowering benefits. Bios Life 2® is used
by thousands.
For more information about the Baycol recall, visit www.fda.gov. To find out more about Bios Life 2®,
visit www.unicitynetwork.com
Baycol contains statins, which make cholesterol levels plummet and have revolutionized the treatment
of high blood pressure since they were introduced in the 1980s. From the beginning, experts noted
that statins caused muscle problems; however, the extent of those problems is only now being discovered.
Officially launched on July 1, 2001, Unicity Network™  represents the
coming together of Rexall Showcase International and Enrich International, two of the most respected
and most successful network marketing and nutritional companies in the industry. The launch of
the company has captured worldwide attention and has been featured in several industry publications.
The company operates in ten different countries.
 

Visit website at www.BL2.info

Click here to download this press release (.PDF)